Keyword: Active Pharmaceutical Ingredients (APIs)
News
02.10.2018
- French drugmaker Sanofi has completed the divestment of its European generics business Zentiva to Advent International effective September 30. The transaction was finalized ahead...
Plant Construction & Process Technology
19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
Plant Construction & Process Technology
19.09.2018
- The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping...
Markets & Companies
19.09.2018
- Having successfully executed over 70 integrated programs with customers, Piramal Pharma Solutions has ample experience in managing multinational project teams. This article...
Markets & Companies
19.09.2018
- The topic of supply chain security is not a new one for the pharmaceutical industry, and much of that discussion has been dominated by the cGMP portion of the API supply chain. The...
Plant Construction & Process Technology
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
Plant Construction & Process Technology
19.09.2018
- Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...
News
25.07.2018
- Cambrex, a US-based small molecule innovator and developer of generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire compatriot Contract Development and...
